Skip to content

A pilot randomised controlled trial of an Acceptance and Commitment Therapy group intervention for family carers of people with dementia

Family Carers of people with dementia: assessing the efficacy of an Acceptance and Commitment Therapy group intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10m9tg2r
Enrollment
Unknown
Registered
2022-08-01
Start date
2021-10-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety

Interventions

Sixty eligible participants will be randomised either to an intervention group (n=30) or a control group (waitlist) (n=30). Participants in the intervention group will receive eight group sessions of
F04.754.137

Sponsors

Universidade Federal de Minas Gerais
Lead Sponsor
University of East Anglia
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Be a family carer of a relative with a clinical diagnosis of dementia; aged 18 and over; identifying oneself as a primary carer in their family; providing a minimum of 28 hours of care each week; having a minimum of four years of formal education; having access to the internet and a device to access online sessions; scoring nine or higher on the Generalised Anxiety Disorder (GAD-7) questionnaire.

Exclusion criteria

Exclusion criteria: Currently receiving psychological therapy

Design outcomes

Primary

MeasureTime frame
Anxiety will be assessed using the Generalised Anxiety Disorder Scale-7 (GAD-7) at three time points: baseline (0 weeks), post-intervention (8 weeks post randomisation) and follow-up (20 weeks post randomisation). The hypothesis of the study is that the group intervention will decrease participants level of anxiety.

Secondary

MeasureTime frame
The following measures will be completed at baseline (0 weeks), post-intervention (8 weeks post randomisation) and follow-up (20 weeks post randomisation): (1) Depression: Patient Health Questionnaire-9 (PHQ-9) and Hospital Anxiety and Depression Scale (HADS-D); (2)Anxiety: Hospital Anxiety and Depression Scale (HADS-A); (3) Carer burden: Zarit Burden Interview Short version; (4) Quality of life: Quality of Life of Alzheimer’s Disease (Qdv-DA); (5) Experiential avoidance: Acceptance and Action Questionnaire-II and Experiential Avoidance in Caregiving Questionnaire.

Countries

Brazil

Contacts

Public ContactMichele Ferreira

Universidade Federal de Minas Gerais

michelegferreira@hotmail.com+55(31)993085754

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 2, 2026